Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine)
Yaelle Bavli, Bing‐Mae Chen, Guy Gross, Alon Y. Hershko, Keren Turjeman, Steve R. Roffler, Yechezkel Barenholz
Topics & Concepts
ReactogenicityVaccinationMedicineAdverse effectPEG ratioPopulationTiterAntibodyImmunologyLiposomePolyethylene glycolVirologyPEGylationImmunoglobulin EPharmacologyImmunogenicityChemistryBiochemistryEconomicsEnvironmental healthFinanceSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesRNA Interference and Gene Delivery